These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31132476)

  • 21. Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis.
    Bodewes FTH; van Asselt AA; Dorrius MD; Greuter MJW; de Bock GH
    Breast; 2022 Dec; 66():62-68. PubMed ID: 36183671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are breast density and bone mineral density independent risk factors for breast cancer?
    Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
    J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis.
    McDonald ES; McCarthy AM; Weinstein SP; Schnall MD; Conant EF
    Radiology; 2017 Dec; 285(3):778-787. PubMed ID: 28715278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Interradiologist Agreement Regarding Mammographic Breast Density Classification Using the Fifth Edition of the BI-RADS Atlas.
    Ekpo EU; Ujong UP; Mello-Thoms C; McEntee MF
    AJR Am J Roentgenol; 2016 May; 206(5):1119-23. PubMed ID: 26999655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening.
    Altas H; Tureli D; Cengic I; Kucukkaya F; Aribal E; Kaya H
    Acta Radiol; 2016 Nov; 57(11):1304-1309. PubMed ID: 26019241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density.
    Destounis S; Johnston L; Highnam R; Arieno A; Morgan R; Chan A
    AJR Am J Roentgenol; 2017 Jan; 208(1):222-227. PubMed ID: 27824483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated with Longitudinal Changes in Mammographic Density in a Multiethnic Breast Screening Cohort of Postmenopausal Women.
    Park HL; Ziogas A; Feig SA; Kirmizi RL; Lee CJ; Alvarez A; Lucia RM; Goodman D; Larsen KM; Kelly R; Anton-Culver H
    Breast J; 2023; 2023():2794603. PubMed ID: 37881237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic Breast Density, Benign Breast Disease, and Subsequent Breast Cancer Risk in 3.9 Million Korean Women.
    Kim S; Tran TXM; Song H; Ryu S; Chang Y; Park B
    Radiology; 2022 Sep; 304(3):534-541. PubMed ID: 35579518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Review of Breast Density Implications and Breast Cancer Screening.
    Lian J; Li K
    Clin Breast Cancer; 2020 Aug; 20(4):283-290. PubMed ID: 32334975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women.
    Han Y; Moore JX; Colditz GA; Toriola AT
    JAMA Netw Open; 2022 Feb; 5(2):e2148983. PubMed ID: 35175341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution and determinants of mammographic density measures in Western Australian aboriginal women.
    McLean K; Darcey E; Cadby G; Lund H; Pilkington L; Redfern A; Thompson S; Saunders C; Wylie E; Stone J
    Breast Cancer Res; 2019 Feb; 21(1):33. PubMed ID: 30819215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Longitudinal Mammographic Breast Density Changes with Subsequent Breast Cancer Risk.
    Tran TXM; Kim S; Song H; Lee E; Park B
    Radiology; 2023 Feb; 306(2):e220291. PubMed ID: 36125380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining quantitative and qualitative breast density measures to assess breast cancer risk.
    Kerlikowske K; Ma L; Scott CG; Mahmoudzadeh AP; Jensen MR; Sprague BL; Henderson LM; Pankratz VS; Cummings SR; Miglioretti DL; Vachon CM; Shepherd JA
    Breast Cancer Res; 2017 Aug; 19(1):97. PubMed ID: 28830497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study.
    Bravi F; Decarli A; Russo AG
    Cancer Med; 2018 May; 7(5):2145-2152. PubMed ID: 29654663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of masking risk in screening mammography with volumetric breast density maps.
    Holland K; van Gils CH; Mann RM; Karssemeijer N
    Breast Cancer Res Treat; 2017 Apr; 162(3):541-548. PubMed ID: 28161786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study.
    Atakpa EC; Buist DSM; Aiello Bowles EJ; Cuzick J; Brentnall AR
    Breast Cancer Res; 2023 Nov; 25(1):147. PubMed ID: 38001476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.